Therapeutic Vaccine in Chronically HIV-1-Infected Patients: A Randomized, Double-Blind, Placebo-Controlled Phase IIa Trial with HTI-TriMix.

Vaccines (Basel) · 2019 · PMC6963294 · PMID 31817794

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

The IFNγ+ T cell responses against the IN peptide showed a trend towards increasing both earlier and to a larger extent in both the HTI-TriMix and TriMix groups as compared to the WFI group.

also in 53,322 other papers

did not reach statistical significanceno p-value reported

The observed differences did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.